Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ACCENTIA BIOPHARMACEUTICALS INC (ABPI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-12Sep-30-12Jun-30-12Mar-31-12Dec-31-11Sep-30-11Jun-30-11Mar-31-11
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Net Sales:          
Products    0.71.0  0.70.8
Services    0.20.2  0.40.4
Grant revenue          
    Total net sales  549.00.70.91.21,232.70.81.11.2
            Total net sales growth  -55.5%-7.5%-15.3%-0.2%135070.0%-125.8%-57.2%-42.1%
Cost of sales:          
Products    0.50.6  0.40.4
Services    0.30.2  0.20.3
Grants          
    Total cost of sales (exclusive of amortization of acquired product rights)    0.70.8  0.60.7
    Gross margin    0.20.4  0.40.6
            Gross margin    19.4%34.8%  41.1%46.2%
   
Operating expenses:          
Research and development    1.11.8  0.70.4
Royalty     0.0   0.0
Sales and marketing    0.00.0  0.00.0
General and administrative    1.23.9  3.03.7
    Total operating expenses    2.35.8  3.74.2
    Operating loss   -11.5-2.2-5.4 -21.2-3.3-3.6
            Operating margin    -240.5%-444.3%  -306.9%-296.2%
   
Other income (expense):          
Interest expense    -1.9-1.9  -1.9-2.1
Derivative gain    1.3-1.5  0.83.8
Other (expense) income    0.00.0 0.00.00.0
    Loss before reorganization items, non-controlling from variable interest entities, discontinued operations and income taxes   -18.0   -28.2  
   
Reorganization items:          
Professional fees   -0.10.00.0 -0.4  
Gain on reorganization    5.10.4  0.70.8
    Total reorganization items    5.10.4  0.70.8
    Loss before discontinued operations, income taxes, and non-controlling interest  -8,733.5-12.42.3-8.5660.5-15.8-3.7-1.0
   
Discontinued operations:          
Income from discontinued operations, including gain from sale of assets        -0.10.0
Income tax expense   -0.6      
    Income from discontinued operations     -0.2  -0.10.0
    Loss before income taxes and non-controlling interest   -9.22.3-8.6 -15.6-3.7-1.0
Income taxes    -0.2  0.00.1 
            Tax rate  0.0%0.0% 0.0%0.0%0.0% 0.0%
    Net loss   -9.22.3-8.6 -15.7-3.7-1.0
Loss from non-controlling interest from variable interest entities and subsidiary    0.82.4  0.90.0
    Loss attributable to common shareholders  -8,733.5-4.33.1-6.2660.5-11.6-2.8-1.1
   
Weighted average shares outstanding, basic and diluted    82.778.3  70.268.8
   
Per share amounts, basic and diluted          
Loss from continuing operations   0.00.00.0 0.00.00.0
   
Loss attributable to common stockholder   ($0.05)$0.04($0.08) ($0.17)($0.03)($0.74)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy